If you are wondering whether Halozyme Therapeutics at around $64.66 is still good value after its run, you are not alone. That is exactly what this breakdown aims to unpack. The stock is up 34.7% year ...

VANCOUVER, BC / ACCESS Newswire / August 7, 2025 / ESGold Corp. (“ESGold” or the “Company”) (CSE:ESAU)(OTCQB:ESAUF)(FSE:Z7D), a clean gold and silver development company, is pleased to provide an ...

If you are wondering whether HCA Healthcare is still a smart buy after such a big run up, or if you are late to the party, ...

The credit score firm partnered with Plaid to bring additional cash-flow data into its previously released UltraFICO score.

Janus International's resilient cash flow, strong margins, and recent S&P credit upgrade highlight its capital-light model. Read why JBI stock is a Strong Buy.

Says 3.2T tokens delivered for customers. Says real value from AI is delivering customer agents. Says expects to finish the ...